HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) saw a significant decline in short interest in December. As of December 30th, there was short interest totalling 3,900 shares, a decline of 40.0% from the December 15th total of 6,500 shares. Based on an average trading volume of 13,400 shares, the short-interest ratio is currently 0.3 days.

HAVN Life Sciences Price Performance

OTCMKTS:HAVLF traded up $0.05 during mid-day trading on Wednesday, hitting $0.10. 5,143 shares of the stock traded hands, compared to its average volume of 14,355. HAVN Life Sciences has a 12-month low of $0.00 and a 12-month high of $4.59. The business's 50-day moving average price is $0.06 and its 200 day moving average price is $0.37.

Get HAVN Life Sciences alerts:

About HAVN Life Sciences

(Get Rating)

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.

Recommended Stories

• Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
• What does Nu Holdings Stock Have To Do With Warren Buffett?
• J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
• Is Intel Stock On The Verge Of Breaking Out?
• Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
• Can Alaska Air Continue Soaring Above The Airline Industry?

Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.